Evidence map›Paper›PMID 30634109›Full record

ArticleDrug and alcohol dependence2019

Cardiovascular effects of 3,4-methylenedioxypyrovalerone (MDPV) in male and female Sprague-Dawley rats.

Samantha J McClenahan, Michael D Hambuchen, Christy M Simecka, Melinda G Gunnell, Michael D Berquist, S Michael Owens

Abstract read
In one paragraph

Article in Drug and alcohol dependence, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Detrimental effects of the 'bath salt' methylenedioxypyrovalerone on social play behavior in male rats.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2020
    Article
  13. Review
  14. Newly Developed Dopamine DThe Journal of pharmacology and experimental therapeutics · 2019
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Samantha J McClenahanDepartment of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
Michael D HambuchenDepartment of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
Christy M SimeckaDivision of Laboratory Medicine, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
Melinda G GunnellDepartment of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
Michael D BerquistDepartment of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
S Michael OwensDepartment of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA. Electronic address: mowens@uams.edu.

Funding

Arkansas Center for Clinical and Translational ResearchUL1TR000039 · NCATS · UNIV OF ARKANSAS FOR MED SCIS · PI BECK, CORNELIA MARIE, JAMES, LAURA P · 2012 to 2014
$10.0M
Translational Training in AddictionT32DA022981 · NIDA · UNIV OF ARKANSAS FOR MED SCIS · PI Melissa Jean Zielinski · 2009 to 2026
$6.1M
Pharmacology and Therapy for MDPV and alpha-PVP Like Drugs of AbuseR01DA039195 · NIDA · UNIV OF ARKANSAS FOR MED SCIS · PI OWENS, SAMUEL MICHAEL · 2015 to 2018
$2.4M
Systems Pharmacology and Toxicology Training ProgramT32GM106999 · NIGMS · UNIV OF ARKANSAS FOR MED SCIS · PI PRATHER, PAUL L · 2013 to 2022
$1.4M
Development of Small-molecule Potentiators of Kir4.1/5.1 Potassium ChannelsF32DK127679 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MCCLENAHAN, SAMANTHA · 2021 to 2022
$86k
Development of an Enantiomeric Specific Vaccine for 3,4-Methylenedioxypyrovalerone (MDPV) AbuseF31DA046121 · NIDA · UNIV OF ARKANSAS FOR MED SCIS · PI MCCLENAHAN, SAMANTHA · 2018 to 2018
$35k
NCATS NIH HHS UL1 TR000039NIDA NIH HHS F31 DA046121NIDA NIH HHS R01 DA039195NIDA NIH HHS T32 DA022981NIDDK NIH HHS F32 DK127679NIGMS NIH HHS T32 GM106999
6 · The paper itself

Abstract

background3,4-methylenedioxypyrovalerone (MDPV) toxicity includes intense neurological and cardiovascular events. We examined MDPV-induced cardiovascular, temperature, and locomotor effects following escalating and repeated MDPV administration in adult male and female Sprague-Dawley rats and compared these effects to cocaine in male rats.

methodsTelemetry devices were surgically implanted to allow continuous measurement of cardiovascular, temperature, and locomotor activity over a 22 h period after dosing. Rats were administered increasing intraperitoneal (IP) MDPV doses (1-5.6 mg/kg) every other day, followed two days later by a binge regimen of four injections of 3 mg/kg MDPV at 2 h intervals. MDPV serum concentrations were measured by LC-MS/MS. Cocaine (3-30 mg/kg) and four injections of 30 mg/kg IP were administered to male rats for comparison with male MDPV data.

resultsThe duration of MDPV cardiovascular effects was significantly greater (p < 0.05) in male rats than female rats at 3-5.6 mg/kg. The ED

conclusionEffects of MDPV on temperature were not significantly different between sexes. MDPV-induced cardiovascular and locomotor effects in males lasted significantly longer and were more potent than in females. These differences appeared to be related to pharmacokinetic factors leading to greater variance in MDPV serum concentrations in males.

Indexed as

Sex CharacteristicsAdrenergic Uptake InhibitorsAnimalsBenzodioxolesBlood PressureCardiovascular SystemDose-Response Relationship, DrugFemaleHeart RateLocomotionMalePsychotropic DrugsPyrrolidinesRatsRats, Sprague-DawleySynthetic CathinoneAdrenergic Uptake InhibitorsBenzodioxolesPsychotropic DrugsPyrrolidinesSynthetic CathinoneCardiovascularMDPVRat sexTelemetry

Identifiers

PMID30634109
PMCPMC6915966

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.